FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
We are very excited to launch our new website! Please take a few moments to click around and explore...